190 related articles for article (PubMed ID: 27020591)
1. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
2. UBE2T knockdown inhibits gastric cancer progression.
Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
5. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
8. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
9. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
[TBL] [Abstract][Full Text] [Related]
10. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
[TBL] [Abstract][Full Text] [Related]
11. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription.
Li L; Liu J; Huang W
Dig Liver Dis; 2022 Jul; 54(7):937-945. PubMed ID: 34583905
[TBL] [Abstract][Full Text] [Related]
12. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway.
Liu Y; Ji W; Yue N; Zhou W
Open Life Sci; 2021; 16(1):1082-1090. PubMed ID: 34703898
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.
Perez-Peña J; Corrales-Sánchez V; Amir E; Pandiella A; Ocana A
Sci Rep; 2017 Dec; 7(1):17530. PubMed ID: 29235520
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
18. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination.
Yu Z; Jiang X; Qin L; Deng H; Wang J; Ren W; Li H; Zhao L; Liu H; Yan H; Shi W; Wang Q; Luo C; Long B; Zhou H; Sun H; Jiao Z
Oncogene; 2021 Feb; 40(5):1027-1042. PubMed ID: 33323973
[TBL] [Abstract][Full Text] [Related]
19. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells.
Gong YQ; Peng D; Ning XH; Yang XY; Li XS; Zhou LQ; Guo YL
Oncol Lett; 2016 Dec; 12(6):4485-4492. PubMed ID: 28101210
[TBL] [Abstract][Full Text] [Related]
20. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
Wu ZH; Zhang YJ; Sun HY
Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]